期刊文献+

松弛素在急性心力衰竭中的研究进展 被引量:4

Research of Relaxin in Acute Heart Failure
原文传递
导出
摘要 急性心力衰竭(AHF)是临床常见疾病,因其具有高发病率、高致死率和高致残率而引起广泛关注。松弛素能增加心输出量、降低血管阻力、增加肾小球滤过率和肾血管流量,因此可使AHF患者受益。结合近年来有关松弛素的基础研究,本文总结归纳了松弛素在治疗AHF中的作用及其相关机制,并对松弛素作为一种治疗AHF的新药在前期临床试验中的结果进行简要介绍。 Summary Acute heart failure(AHF), a common clinical disease, has caused much concern because of its high morbidity and mortality. Relaxin may benefit AHF patients with functions of increasing cardiac output, glo- merular filtration rate, renal vascular flow and reducing vascular resistance. The present review primarily focuses on the related mechanisms of relaxin in the treatment of AHF. and makes a brief summary of relaxin on its out- comes in preclinical trials as a new drug for AHF.
作者 范致星 杨简
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2014年第9期819-821,共3页 Journal of Clinical Cardiology
基金 国家自然科学基金项目(No:81200088) 宜昌市科技研究与开发项目(No:A12301-01)
关键词 急性心力衰竭 松弛素 作用机制 临床研究 acute heart failure relaxin mechanism clinical research
  • 相关文献

参考文献18

  • 1张晓卉,隋宇玢,陈文佳,尹新华.松弛素的心血管效应[J].生理科学进展,2013,44(5):381-385. 被引量:1
  • 2SHERWOOD O D. Relaxin's physiological roles and other diverse actions[J]. Endocr Rev, 2004, 25:205 -234.
  • 3BATHGATE R A, IVELL R, SANBORN B M, et al. International Union of Pharmacology: Recommen- dations for the nomenclature of receptors for relaxin family peptides[J]. Pharmacol Rev, 2006, 58: 7- 31.
  • 4ZHANGJ, QI YF, TANG CS, et al. Effect of re- laxin on myocardial ischemia injury induced by isopro- terenol[J]. Peptides, 2005, 26 : 1632 - 1639.
  • 5CONRAD K P. Maternal vasodilation in pregnancy:the emerging role of relaxin[J]. Am J Physiol Regul Integr Comp Physiol, 2011, 301 : R267- R275.
  • 6卢永昕.2012年心力衰竭治疗的更新与探索[J].临床心血管病杂志,2013,29(4):241-243. 被引量:3
  • 7DU X J, BATHGATE R A D, SAMUEL C S, et al. Cardiovascular effects of relaxin: from basic science to clinical therapy[J]. Nat Rev Cardiol, 2010, 7: 48- 58.
  • 8CONRAD K R. Maternal vasodilation in pregnaney: the emerging role of relaxin[J]. Am J Physiol Regul Integr Comp Physiol, 2011, 301: R267-R275.
  • 9NOVAK J, DANIELSON L A, KERCHNER L J, et al. Relaxin is essential for renal vasodilation during pregnancy in conscious rats[J]. J Clin Invest, 2001, 107:1469-1475.
  • 10DANIELSON L A, CONRAD K P. Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats[J]. J Appl Physiol, 2003, 95 : 1509- 1514.

二级参考文献22

  • 1MCMURRAY J J, ADAMOPOUI.OS S, ANKER S D, et al. ESC guidelines for the diagnosis and treat- ment of acute and chronic heart failure 2012[J]. Eur J Heart, 2012,33:1787-- 1847.
  • 2TEERLINK J R, COTTER G, DAVISON B A, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomized, placebo-controlled trial [J]. Lancet, 2013,381:29--39.
  • 3SOLOMON S D, ZlLE M, PIESKE B, et al. The an- giotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial [J]. Lancet, 2012,380 :1387 -- 1395.
  • 4PERIN E C, WILLERSON J T, PEPINE C J, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial[J]. JAMA, 2012, 307:1717--1726.
  • 5CHUGH A R, BEACHE G M, LOUGHRAN J H, et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: sur-gical aspects and interim analysis of myocardial func- tion and viability by magnetic resonance[J]. Circula- tion,2012,126(11 Suppl 1) :S54--64.
  • 6MAKKAR R R, SMITH R R, CHENG K, et al. In- tracoronary cardiosphere-derived cells for heart regen- eration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial[J].Lancet, 2012,379:895--904.
  • 7Drongelen JV, Ploemen IHJ, Pertijs J, et al. Aging attenu- ates the vasodilator response to relaxin. Am J Physiol Heart Circ Physiol, 2011, 300 : H1609- H1615.
  • 8Dschietzig T, Alexiou K, Kinkel HT, et al. The positive in- otropic effect of relaxin-2 in human atrial myocardium is pre- served in end-stage heart failure: role of G (i)-phos- phoinositide-3 kinase signaling. J Card Fail, 2011, 17 : 158 - 166.
  • 9Nistri S, Cinci L, Perna AM, et al. Mast cell inhibition and reduced ventrieular arrhythmias in a swine model of acute myocardial infarction upon therapeutic administration of re- laxin. Inflamm Res, 2008, 57 Suppl 1 : $7 - $8.
  • 10Formigli L, Perna AM, Meaeei E, et al. Paraerine effects of transplanted myoblasts and relaxin on post-infarction heart remodeling. J Cell Mol Med, 2007, 11 : 1087 - I100.

共引文献2

同被引文献38

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部